Investor Disclaimer

The materials on this website and, in particular, the Investor Relations section of this website, may contain information considered to be forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts are forward-looking statements. Forward-looking statements can be identified by the use of words such as “anticipate,” “intend,” “believe,” “anticipate,” “estimate,” “plan,” “seek,” “project,” “expect,” “may,” “will,” “would,” “could,” “should,” the negative of these terms or other comparable terminology. Examples of forward-looking statements include statements concerning future strategic objectives, business prospects, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and strategic partnerships, the only company with both long-read and short-read platforms, regulatory developments, or general economic conditions.

Readers are cautioned not to place undue reliance on forward-looking statements, as actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to our financial situation, commercial success of our products and technologies, the ability to develop current and future products, industry competition, the ability to leverage new acquisitions or strategic partnerships such as our acquisitions of Omniome and Circulomics and our partnership with Invitae, the ability to expand our sales and customer base, other companies potentially having both long-read and short-read platforms, legislation or regulations affecting product demand or access, the ability to protect our patents and other intellectual property both domestically and internationally, the availability of materials and suppliers, manufacturing issues, the ability to retain key personnel and other known and unknown risks and uncertainties. These and other risks are described in detail in our most recently filed Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, which are available at https://investor.pacificbiosciences.com/ and the SEC website at http://www.sec.gov.

Prior press releases are archived on this website for historical purposes only. Information contained in such releases is accurate at the time of release. Specific information in these releases may change over time, and may or may not be accurate after the date on the release. We disclaim any obligation to update or revise any forward-looking statements or information contained in historical press releases.

STOCK QUOTE

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor
Contact

Pacific Biosciences

1305 O’Brien Drive

Menlo Park, CA  94025

ir@pacb.com